Additionally, treatment with mesalamine (an anti-inflammatory drug used to treat ulcerative colitis) increases MGAT3 expression in mice intestinal polyps (which normally show a low expression of MGAT3) [109]. This evidence concerns the gene MGAT3 and ulcerative colitis.